Healthcare Services

The Symbiotic Surge Of Chronic Diseases And The Drug Discovery Services Market Continues To Impact The Growth Of The Drug Discovery Services Market

May 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Forecasted Market Size Figures For The Drug Discovery Services Market In 2026 And 2030?

The drug discovery services market size has experienced significant expansion recently. Its valuation is projected to rise from $20.52 billion in 2025 to $23.21 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 13.1%. Historically, this growth has been driven by factors such as pharmaceutical r&d expansion, cost pressures on drug developers, cro service growth, target-based drug discovery, and academic-industry collaborations.

The drug discovery services market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $39.79 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.4%. The projected growth during this period stems from factors such as precision medicine pipelines, AI-driven discovery platforms, increased startup biotech funding, advancements in complex disease research, and the need for more rapid lead optimization. Key trends foreseen for the forecast timeframe encompass the rising outsourcing of drug discovery activities, the expanded application of AI in target identification, the broadening of early-stage discovery services, an escalating demand for biologics drug discovery, and the enhanced integration of in vitro and in vivo studies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8324&type=smp

Which Strategic Drivers Are Supporting The Drug Discovery Services Market Development?

The increasing occurrence of chronic diseases is anticipated to drive expansion in the drug discovery services market in the future. These conditions are defined as persistent health ailments that are typically incurable but manageable. The services involved in drug discovery are crucial for identifying and creating novel medicines aimed at treating chronic illnesses. A relevant example illustrates this: in September 2023, the World Health Organization, an intergovernmental public health agency based in Switzerland, reported that chronic noncommunicable diseases led to 41 million deaths each year, accounting for 74% of all fatalities worldwide. Consequently, the expanding incidence of chronic diseases will contribute to the growth of the drug discovery services market.

Which Segment Divisions Form The Structure Of The Drug Discovery Services Market?

The drug discovery services market covered in this report is segmented –

1) By Type: Chemistry Services, Biology Services

2) By Process: Target Selection, Target Validation, Hit-To-Lead identification, Lead Optimization, Candidate Validation

3) By Drug Type: Biologics Drug , Small Molecule Drug

4) By End user: Pharmaceutical And Biotechnology Companies, Academic Institutes, Other End Users

Subsegments:

1) By Chemistry Services: Medicinal Chemistry, Compound Management, High-Throughput Screening, Lead Optimization

2) By Biology Services: In Vitro Studies, In Vivo Studies, Pharmacokinetics And Pharmacodynamics (PK Or PD), Biomarker Discovery

What Trends Are Affecting The Growth Of The Drug Discovery Services Market?

Leading companies in the drug discovery services market are integrating advanced technologies, such as artificial intelligence (AI) and machine learning (ML), to improve the efficiency and accuracy of the drug discovery process. Artificial Intelligence (AI) and Machine Learning (ML) are related domains within computer science. AI pertains to developing computer systems that can execute tasks typically requiring human cognitive abilities. ML, a subfield of AI, focuses on using algorithms and statistical models that allow computers to learn from data and consequently make forecasts or judgments. For example, in February 2024, Eurofins Discovery, a France-based firm offering support services across diverse sectors, including pharmaceuticals, announced the introduction of its innovative platform named DiscoveryAI SAFIRE (Suite of ADMET Predictions for In Silico Refinement and Evaluation). This sophisticated platform leverages proprietary datasets, artificial intelligence (AI), and machine learning (ML) to enhance the drug discovery workflow. SAFIRE is designed to expedite the identification of new pharmaceuticals by predicting the ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties of molecules. The platform utilizes data from Eurofins Discovery’s comprehensive BioPrint database, which has been meticulously collected over years of research.

Which Companies Are Engaged In The Drug Discovery Services Market Environment?

Major companies operating in the drug discovery services market are Thermo Fisher Scientific Inc., Albany Molecular Research Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, Domainex Ltd., GenScript Biotech Corporation, Pharmaceutical Product Development LLC, Advinus Therapeutics Pvt. Ltd., Jubilant Biosys Ltd., Evotec AG, Syngene International Ltd., Bayer AG, Merck KGaA, Ubiquigent Ltd., Eurofins Scientific SE, AppTec Laboratory Services Inc., GVK Biosciences Private Limited, Aurigene Discovery Technologies Limited, Viva Biotech Holdings, Pharmaron Beijing Co. Ltd., Selcia Limited, Concept Life Sciences Group Limited, BioDuro LLC, ChemPartner Corporation, Aptuit LLC, Sygnature Discovery Limited, Peak Proteins Ltd., SRI International, BioAscent Discovery Limited, Sai Life Sciences Limited, Promega Corporation, MedChemExpress LLC, Aragen Bioscience Inc., WuXi STA, BioNTech SE, Moderna Inc., Gilead Sciences Inc., Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals Inc., Amgen Inc., Bristol-Myers Squibb Company

Access The Complete Drug Discovery Services Market Report:

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Which Region Leads The Drug Discovery Services Market By Size?

North America was the largest region in the drug discovery services market in 2025. The regions covered in the drug discovery services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Drug Discovery Services Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=8324&type=smp

Browse Through More Reports Similar to the Global Drug Discovery Services Market 2026, By The Business Research Company

Drug Discovery Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Drug Discovery Technologies Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-technologies-global-market-report

Drug Discovery Informatics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-informatics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795